Newsfeeds - Spark Newswire

1 minute read

vTv Therapeutics Q4 EPS $(0.06), Inline, Sales $9.00K, Same YoY

Today, 9:29 PM

vTv Therapeutics (NASDAQ:VTVT) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. This is a 45.45 percent increase over losses of $(0.11) per share from the same period last year.

VTVT

1 minute read

FDA
News

Cantex and Miami Cancer Institute Announce FDA Clearance for a Clinical Trial Investigating Azeliragon Combined with Stereotactic Radiosurgery for the Treatment of Brain Metastases

By Benzinga Newsdesk

Today, 9:29 PM

Cantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other life-threatening medical conditions, and Baptist Health Miami Cancer

VTVT

1 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Pre-Market Session

By Benzinga Insights

Today, 9:29 PM

Gainers Prenetics Global (NASDAQ:PRE) stock rose 74.7% to $3.25 during Tuesday’s pre-market session. The market value of their…

APGN

2 minute read

Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights

Today, 9:29 PM

Gainers Passage Bio (NASDAQ:PASG) shares moved upwards by 7.7% to $2.66 during Friday's after-market session. The market value of their outstanding shares is at $144.4 million.

ATXS

1 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

Today, 9:29 PM

Gainers ABVC BioPharma (NASDAQ:ABVC) shares increased by 12.3% to $1.03 during Wednesday's after-market session. The company's market cap stands at $33.2 million.

ABVC

1 minute read

FDA
News

vTv Therapeutics Shares Move Higher; Co Granted Canadian Patent Titled ‘TREATMENT OF MILD AND MODERATE ALZHEIMER’S DISEASE’

By Benzinga Newsdesk

Today, 9:29 PM

Primary Analysis For All Patients Treated In This Ragnar Cohort, Known As Broad Panel Cohort, Is Anticipated Later This Year

VTVT

2 minute read

Aravive Names Rudy Howard as CFO

By Charles Gross

Today, 9:29 PM

Aravive, Inc. (Nasdaq: ARAV, the "Company"), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today announced the appointment of Rudy Howard as Chief Financial Officer, effective today. Vinay Shah has stepped down as CFO for personal reasons but will remain with the Company as an advisor to ensure a smooth transition.

ARAV